<DOC>
	<DOCNO>NCT00667433</DOCNO>
	<brief_summary>This single arm , longitudinal study examine safety , tolerability , pharmacokinetic metabolic characteristic Raltegravir among 40 African-American , HIV-infected , patient .</brief_summary>
	<brief_title>Raltegravir Early Therapy African-Americans Living With HIV Study</brief_title>
	<detailed_description>Purpose : This study single arm , prospective cohort study examine safety , efficacy , pharmacokinetic metabolic characteristic Raltegravir African-American men woman . Participants : 40 HIV positive , ARV treatment-naive , African-American woman men ( estimate 70 % men , 30 % woman ) Procedures ( method ) : Subjects receive Raltegravir 400 mg BID along Truvada 104 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>HIV1 infection document HIV serology detectable viral load Selfdescribed AfricanAmerican Less 7 day cumulative prior HIV therapy Plasma HIV RNA PCR equal great 1000 copies/mL within 90 day prior study entry Able provide inform consent In opinion investigator , able comply study medication procedure ALT ( SGPT ) &lt; equal 3.0 x ULN within 45 day prior study entry GRF &gt; 59 calculated MDRD within 45 day prior study entry All woman reproductive potential ( reach menopause undergone hysterectomy , bilateral oophorectomy , tubal ligation ) must negative serum urine βHCG pregnancy test perform within 48 hour entry . All study volunteer must agree participate conception process ( e.g. , active attempt become pregnant impregnate , sperm donation , vitro fertilization ) , participate sexual activity could lead pregnancy , female study volunteer/male partner must use least one reliable method contraception ( e.g. , condom , without spermicidal agent ; diaphragm cervical cap spermicide ; IUD ; hormonalbased contraception ) , simultaneously receive protocolspecified medication ( ) 6 week stop medication ( ) . If oral birth control pill , hormone patch , hormone injection use contraception , second method contraception must use . Pregnancy Breastfeeding Prior receipt Raltegravir Any condition opinion investigator likely interfere followup ability take study medication appropriately</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>African American</keyword>
	<keyword>treatment naïve</keyword>
</DOC>